spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  bioreactor system 

 HSMN NewsFeed - 12 Apr 2010
Xcellerex Announces Appointment of Guy Broadbent as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jun 2009
Pluristem Therapeutics Receives European Regulatory Approval for Placental-Derived Stem Cell Clinical Trial
Regenerative Medicine
 HSMN NewsFeed - 12 May 2008
HepaLife's Bioartificial Liver Exceeds Expectations in New Tests Conducted over Prolonged Periods of Time
Devices
 HSMN NewsFeed - 11 Oct 2007
Xcellerex Raises $31 Million in Series C Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 13 Aug 2007
HepaLife(TM) Bioartificial Liver: Analysts Forecast Artificial Liver Market to Surpass $2.7 Billion by 2010
Devices
 HSMN NewsFeed - 9 Jul 2007
HepaLife Expands Scientific Team and Continues Development of First-of-its-Kind Artificial Liver Device
Devices Personnel
 HSMN NewsFeed - 4 May 2007
Xcellerex Announces Appointment of Joseph Zakrzewski as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Apr 2007
HepaLife Achieves Major Milestone in Development of Artificial Liver Device
Devices
 HSMN NewsFeed - 18 Apr 2007
Protalix BioTherapeutics, Inc. Receives Approval from the FDA to Initiate a Phase III Clinical Trial of prGCD
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Mar 2007
Orthodontix Announces Name Change to Protalix BioTherapeutics, Inc.
Biopharmaceuticals
 HSMN NewsFeed - 26 Sep 2006
Teva Pharmaceutical Industries Ltd. and Protalix Biotherapeutics Ltd. Announce a Collaboration Agreement for the Development of Two Biopharmaceuticals, Based on Protalix's Recombinant Plant Cell Expression Technology
Biopharmaceuticals Licensing
 HSMN NewsFeed - 5 May 2006
Millenium Biologix provides update on ACTES(TM) Regulatory Strategy, withdraws Peptos(TM) IDE Submission, and announces senior management change
Devices Regulatory Personnel
Return to NewsFeed  

 Additional items found! 6

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 6 additional stories matching:
bioreactor system
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.